Hosted on MSN26d
Mersana therapeutics director Anna Protopapas sells $3,900 in stock
Anna Protopapas, a director at Mersana Therapeutics Inc . (NASDAQ:MRSN), recently reported a sale of company stock, according to a filing with the Securities and Exchange Commission. On January 15 ...
Finanznachrichten1mon
Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
Mersana Therapeutics-Direktorin Anna Protopapas verkauft Aktien im Wert von 3.900 US-Dollar 16.01. Mersana Therapeutics SVP verkauft Aktien im Wert von 1.468 US-Dollar ...